Management Change29 May 2026, 10:41 pm
Gujarat Terce Labs Reappoints Aalap Prajapati as MD & CEO
AI Summary
Gujarat Terce Laboratories Ltd has re-appointed Mr. Aalap Prajapati as the Managing Director & CEO for a term of 5 years, effective from October 28, 2026, to October 27, 2031. This decision, based on the Nomination and Remuneration Committee's recommendations, was approved by the Board of Directors on May 29, 2026, and is subject to shareholder approval at the upcoming 41st Annual General Meeting. Mr. Prajapati has over 15 years of experience in the pharmaceutical sector.
Key Highlights
- Aalap Prajapati re-appointed as MD & CEO of Gujarat Terce Labs.
- Re-appointment is for 5 years, effective October 28, 2026.
- Shareholder approval is required at the 41st AGM.
- Prajapati has 15+ years of experience in the pharmaceutical sector.
- He is the son of Whole-Time Director, Mr. Natwarbhai Prajapati.
Price Impact
More from GUJTERC